FDA grants accelerated approval to controversial muscular dystrophy drug

Short resume:

sign
90%
request
80%
business
80%
timely
70%
FDA grants accelerated approval to controversial muscular dystrophy drug

After months of advocacy and speculation, the Food and Drug Administration today granted accelerated approval to the first treatment for a rare form of muscular dystrophy.
Source Washington Post
Read More…

More News

Be the first to comment

Leave a Reply

Your email address will not be published.


*